Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
Status:
Approved for marketing
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide posaconazole compassionate treatment to patients with
invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for
which there are no effective therapies; 3) with a prior history of serious, severe, or
life-threatening toxicities while receiving standard antifungal therapies, or 4) with
pre-existing organ dysfunction which precludes the use of standard antifungal therapies.